Design, synthesis and binding affinity of new nicotinic ligands

Arkivoc

Volumn 2006, Issue 8, 2006, Pages 60-65

  Guandalini, Luca ^a   Martini, Elisabetta ^a   Gratteri, Paola ^a   Ghelardini, Carla ^a   Varani, Katia ^b   Romanellia, Maria Novella ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Docking studies; Nicotinic receptor; Subtype selectivity

Indexed keywords

EID: 33744477612     PISSN: 14246376     EISSN: 14246376     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (69)

1. Kagan, B. L.; Azimov, R.; Azimova, R. J. Membrane Biol. 2004, 202, 1.
2. Scarpini, E.; Scheltens, P.; Feldman, H. Lancet Neurol. 2003, 2, 539.
3. Tariot, P. N.; Federoff, H. J. Alzheimer Dis. Assoc. Disord. 2003, 17, S105.
4. Aracava, Y.; Pereira, E. F. R.; Maelicke, A.; Albuquerque, E. X. J. Pharmacol. Exp. Ther. 2005, 312, 1195.
5. Banerjee, P.; Samoriski, G.; Gupta, S. J. Pharmacol. Exp. Ther. 2005, 313, 928.
6. Nordberg, A. Biol. Psychiatry 2001, 49, 200.
7. Singh, A.; Potter, A.; Newhouse, P. IDrugs 2004, 7, 1096.
8. Jensen, A. A.; Frølund, B.; Liljefors, T.; Krogsgaard-Larsen, P. J. Med. Chem. 2005, 48, 4705.
9. Sher, E.; Chen, Y.; Sharples, T. J.; Broad, L. M.; Benedetti, G.; Zwart, R.; McPhie, G. I.; Pearson, K. H.; Baldwinson, T.; De Filippi, G. Curr. Top. Med. Chem. 2004, 4, 283.
10. Picciotto, M. R.; Caldarone, B. J.; Brunzell, D. H.; Zachariou, V.; Stevens, T. R.; King, S. L. Pharmacol. Ther. 2001, 92, 89.
11. Buccafusco, J. J.; Letchworth, S. R.; Bencherif, M.; Lippiello, P. M. Trends Pharmacol. Sci. 2005, 26, 352.
12. Dougherty, J. J.; Wu, J.; Nichols, R. A. J. Neurosci. 2003, 23, 6740.
13. Dineley, K. T.; Bell, K.; Bui, D.; Sweatt, J. D. J. Biol. Chem. 2002, 277, 25056.
14. Fu, W.; Jhamandas, J. H. J. Neurophysiol. 2003, 90, 3130.
15. Pettit, D. L.; Shao, Z.; Yakel, J. L. J. Neurosci. 2001, 21, RC120.
16. Lamb, P. W.; Melton, M. A.; Yakel, J. L. J. Mol. Neurosci. 2005, 27.
17. Snyder, E. M.; Nong, Y.; Almeida, C. G.; Paul, S.; Moran, T.; Choi, E. Y.; Nairn, A. C.; Salter, M. W.; Lombroso, P. J.; Gouras, G. K.; Greengard, P. Nat. Neurosci. 2005, 8, 1051.
18. Hogg, R. C.; Raggenbass, M.; Bertrand, D. Rev. Physiol. Biochem. Pharmacol. 2003, 147, 1.
19. Deutsch, S. I.; Rosse, R. B.; Schwartz, B. L.; Weitzman, A.; Chilton, M.; Arnold, D. S.; Mastropaolo, J. Isr. J. Psychiatry Relat. Sci. 2005, 42, 33.
20. Araki, H.; Suemaru, K.; Gomita, Y. Jpn. J. Pharmacol. 2002, 88, 133.
21. Popik, P.; Krawczyk, M.; Kos, T.; Nalepa, I.; Kowalska, M.; Witarski, T.; Antkiewicz-Michaluk, L.; Vetulani, J. Eur. J. Pharmacol. 2005, 515, 128.
22. Caldarone, B. J.; Harrist, A.; Cleary, M. A.; Beech, R. D.; King, S. L.; Picciotto, M. R. Biol. Psychiatry 2004, 56, 657.
23. Jain, K. K. Curr. Opin. Investigat. Drugs 2004, 5, 76.
24. Wilens, T. E.; Verlinden, M. H.; Adler, L. A.; Wozniak, P. J.; West, S. A. Biol. Psychiatry 2006, in press.
25. Fagerström, K.; Balfour, D. Expert Opin. Investing. Drugs 2006, 15, 107.
26. Lippiello, P. M. Med. Hypotheses 2006, 66, 985.
27. Hogg, R. C.; Bertrand, D. Bioorg. Med. Chem. Lett. 2004, 14, 1859.
28. Daly, J. W. Cell. Mol. Neurobiol. 2005, 25, 513.
29. Coe, J. W.; Brooks, P. R.; Vetelino, M. G.; Wirtz, M. C.; Arnold, E. P.; Huang, J.; Sands, S. B.; Davis, T. I.; Lebel, L. A.; Fox, C. B.; Shrikhande, A.; Heym, J. H.; Schaeffer, E.; Rollema, H.; Lu, Y.; Mansbach, R. S.; Chambers, L. K.; Rovetti, C. C.; Schulz, D. W.; Tingley, F. D. I.; O'Neill, B. T. J. Med. Chem. 2005, 48, 3474.
30. Brejc, K.; van Dijk, W. J.; Klaassen, R. V.; Schuurmans, M.; van der Oost, J.; Smit, A. B.; Sixma, T. K. Nature 2001, 411, 269.
31. Celie, P. H. N.; van Rossum-Fikkert, S. E.; van Dijk, W. J.; Brejc, K.; Smit, A. B.; Sixma, T. K. Neuron 2004, 41, 907.
32. Celie, P. H. N.; Kasheverov, I. E.; Mordvintsev, D. Y.; Hogg, R. C.; van Nierop, P.; van Elk, R.; van Rossum-Fikkert, S. E.; Zhmak, M. N.; Bertrand, D.; Tsetlin, V.; Sixma, T. K.; Smit, A. B. Nat. Struct. Mol. Biol. 2005, 12, 582.
33. Celie, P. H. N.; Klaassen, R. V.; van Rossum-Fikkert, S. E.; van Elk, R.; van Nierop, P.; Smit, A. B.; Sixma, T. K. J. Biol. Chem. 2005, 280, 26457.
34. Schapira, M.; Abagyan, R.; Totrov, M. BMC Struct. Biol. 2002, 2, 1.
35. Le Novère, N.; Grutter, T.; Changeux, J.-P. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 3210.
36. Costa, V.; Nistri, A.; Cavalli, A.; Carloni, P. Br. J. Pharmacol. 2003, 140, 912.
37. Bisson, W. H.; Scapozza, L.; Westera, G.; Mu, L.; Schubiger, P. A. J. Med. Chem. 2005, 48, 5123.
38. Unwin, N. J. Mol. Biol. 2005, 346, 967.
39. Taly, A.; Delarue, M.; Grutter, T.; Nilges, M.; Le Novère, N.; Corringer, P.-J.; Changeux, J.-P. Biophys. J. 2005, 88, 3954.
40. Miyazawa, A.; Fujiyoshi, Y.; Unwin, N. Nature 2003, 423, 949.
41. Cassels, B. K.; Bermúdez, I.; Dajas, F.; Abin-Carriquiry, J. A.; Wonnacott, S. Drug Discovery Today 2005, 10, 1657.
42. Martin, Y. C. J. Med. Chem. 1992, 35, 2145.
43. Sheridan, R. P.; Venkataraghavan, R. J. Comput.-Aided Mol. Des. 1987, 1, 243.
44. Guandalini, L.; Martini, E.; Dei, S.; Manetti, D.; Scapecchi, S.; Teodori, E.; Romanelli, M. N.; Varani, K.; Greco, G.; Spadola, L.; Novellino, E. Bioorg. Med. Chem. 2005, 13, 799.
45. Kanne, D. B.; Abood, L. G. J. Med. Chem. 1988, 31, 506.
46. Kanne, D. B.; Tomizawa, M.; Durkin, K. A.; Casida, J. E. Bioorg. Med. Chem. Lett. 2005, 15, 877.
47. Beers, W. H.; Reich, E. Nature 1970, 225, 917.
48. Glennon, R. A.; Herndon, J. L.; Dukat, M. Med.Chem. Res. 1994, 4, 461.
49. Abreo, M. A.; Lin, N.-H.; Garvey, D. S.; Gunn, D. E.; Hettinger, A.-M.; Wasicak, J. T.; Pavlik, P. A.; Martin, Y. C.; Donnelly-Roberts, D. L.; Anderson, D. J.; Sullivan, J. P.; Williams, M.; Arneric, S. P.; Holladay, M. W. J. Med. Chem. 1996, 39, 817.
50. Romanelli, M. N.; Manetti, D.; Scapecchi, S.; Borea, P. A.; Dei, S.; Bartolini, A.; Ghelardini, C.; Gualtieri, F.; Guandalini, L.; Varani, K. J. Med. Chem. 2001, 44, 3946.
51. Rericha, A.; Seidal, I.; Robisch, G. Cryst. Res. and Technol. 1990, 25, 1049.
52. Glennon, R. A.; Maarouf, A.; Fahmy, S.; Martin, B.; Fan, F.; Yousif, M.; Shafik, R. M.; Dukat, M. Med. Chem. Res. 1993, 2, 546.
53. Dukat, M.; Fiedler, W.; Dumas, D.; Damaj, M. I.; Martin, B. R.; Rosecrans, J. A.; James, J. R.; Glennon, R. A. Eur. J. Med. Chem. 1996, 31, 875.
54. Lee, M.; Dukat, M.; Liao, L.; Flammia, D.; Damaj, M. I.; Martin, B.; Glennon, R. A. Bioorg. Med. Chem. Lett. 2002, 12, 1989.
55. Elliott, R. L.; Kopecka, H.; Gunn, D. E.; Lin, N.-H.; Garvey, D. S.; Ryther, K. B.; Holladay, M. W.; Anderson, D. J.; Campbell, J. E.; Sullivan, J. P.; Buckley, M. J.; Gunther, K. L.; O'Neill, A. B.; Decker, M. W.; Arneric, S. P. Bioorg. Med. Chem. Lett. 1996, 6, 2283.
56. Schmitt, J. D. Curr. Med. Chem. 2000, 7, 749.
57. Beene, D. L.; Brandt, G. S.; Zhong, W.; Zacharias, N. M.; Lester, H. A.; Dougherty, D. A. Biochemistry 2002, 41, 10262.
58. O'Callaghan, J. P.; Holtzman, S. G. J. Pharmacol. Exp. Ther. 1975, 192, 497.
59. Glennon, R. A.; Dukat, M. Bioorg. Med. Chem. Lett. 2004, 14, 1841.
60. Dogruer, D.; Lee, M.; Dukat, M.; Damaj, M. I.; Martin, B.; Glennon, R. A. Bioorg. Med. Chem. Lett. 2004, 14, 523.
61. Compounds, in all the possible conformations, were built using Spartan (V 1.01, Wavefunction) and geometry optimized using AM1.
62. 13C]NMR. The elemental analysis of the final compounds are within 0.4% of the theoretical values.
63. Schrödinger Induced Fit Protocol using Glide 3.5 and Prime 1.2. (http://www.schroedinger.com) Default input parameters were used for the induced-fit computations, i.e. 0.5 scaling factor for the vdW radii of both ligand and receptor; refinement of residues within 5 Å from the ligand poses, 20 poses of the docked complex.
64. Jorgensen, W. L.; Maxwell, D. S.; Tirado-Rives, J. J. Am. Chem. Soc. 1996, 118, 11225.
65. Work is in progress to include the water molecules in the docking studies.
66. Arias, H. R. Neurochem. Int. 2000, 36, 595.
67. Compound 6 has been studied only as racemate; the (S) isomer has been used for docking studies. The protonation on the pyrrolidine nitrogen introduces a second stereogenic centre; both SR and SS isomers have been docked into the receptor, but only the SR isomer is shown in this work.
68. Parker, M. J.; Beck, A.; Luetje, C. W. Mol. Pharmacol. 1998, 54, 1132.
69. Wei, Z.-L.; Xiao, Y.; Yuan, H.; Baydyuk, M.; Petukhov, P. A.; Musachio, J. L.; Kellar, K. J.; Kozilowski, A. P. J. Med. Chem. 2005, 48, 1721.